Exchange: NASDAQ·Updated 07:48 PM EDT
MGX logo

MGX Metagenomi Inc.

$1.17
$0.01
(0.86%)
Today
Closed $1.17
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$44.2M
Vol54,806.00

About MGX

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
43

Bearish Sentiment

How do you feel about MGX?

Advertisement|Remove ads.